Our previous work revealed that galectin-3 can influence the course of psoriasis and cardiometabolic comorbidities; moreover, galectins-1, 2 and 12 may be involved in metabolic complications associated with psoriasis [11,12]. The gene discussed is LGALS1; the disease is psoriasis.